A preliminary clinical study at Johns Hopkins Kimmel Cancer Center demonstrated that antibody treatment could decrease by half the number of cancer stem cells, which…
News
The diagnosis and management of myeloma in the very elderly is especially challenging, despite improvements in therapies. A review study, “Multiple myeloma in the very…
A research team led by William Matsui, MD, and Carol Ann Huff, MD, with the Johns Hopkins Kimmel Cancer Center, has found that MedImmune’s novel MEDI-551 antibody treatment…
Advocates working to raise awareness and funds for multiple myeloma successfully climbed Mount Kilimanjaro, and a documentary about the climb premiered last month at the Eden…
A screening study — the largest of its kind for myeloma — hopes to find a way to prevent myeloma before it develops. The study, called iStopMM…
Recent Posts
- Just like Spider-Man does, myeloma patients can find comfort in community
- Global team aims to harness natural killer cells to target myeloma
- FDA grants orphan drug status to potential treatment for ALL
- When time splits in two: The before and after of ordinary objects
- Targeted myeloma treatment shows promise in Phase 1 trial
